Endocrinology & Metabolism

What our endocrinology unit covers

Endocrinology is the medicine of hormones — the chemical signals that set your metabolism, energy, temperature, weight, mood, bones, blood sugar and fertility — and of the glands that make them: thyroid, adrenals, pituitary, parathyroids and pancreas. It is a specialty of interpretation more than of procedures: the organ is rarely seen or touched, and almost everything turns on reading the right tests in the right context. At Acıbadem International the endocrinology and metabolism unit works across the group’s hospitals as the place where an abnormal hormone number stops being a frightening line on a report and becomes either a diagnosis with a plan, or — just as valuably — a documented non-problem.

The work falls into six strands.

• Thyroid disease — hypothyroidism and hyperthyroidism, Hashimoto’s and Graves’ disease, thyroiditis and goiter, and the reading of thyroid tests done properly.
• The thyroid nodule pathway — from a lump or an incidental scan finding through ultrasound, TIRADS scoring and biopsy to a decision, with surgery involved only when it should be.
• Adrenal problems — cortisol excess and deficiency, adrenal nodules found by accident, and hormone-driven hypertension.
• Pituitary problems — prolactinoma, acromegaly and other master-gland disorders, managed with medicine first wherever medicine is the treatment.
• Parathyroid and calcium — high calcium worked up properly, and the decision about parathyroid surgery.
• Diabetes and metabolism — type 1, type 2 and the atypical forms in between (LADA, MODY), insulin resistance, and honest answers about blood sugar targets.

Boundaries, named at the start. Thyroid and parathyroid operations belong to general surgery and pituitary operations to neurosurgery — this unit decides with you whether an operation is needed at all. Radioactive iodine treatment is delivered by nuclear medicine. The reproductive side of hormones — PCOS treatment, fertility, menopause — lives with gynaecology and reproductive medicine; the isolated abnormal result in a person who feels well is internal medicine’s opening question; and weight-loss surgery decisions belong to bariatric surgery. Endocrinology is the hub those roads meet in the middle of.

What does an endocrinologist do?

What does an endocrinologist do that a general doctor cannot? An endocrinologist is the specialist physician of hormone systems — the “thyroid doctor” or “hormone doctor” most patients are actually looking for when they type those words — and the honest answer is: they interpret. Hormones move with time of day, stress, sleep, medicines, other illness and the assay used to measure them, so the same number can be disease in one person and noise in another. The endocrinologist’s craft is ordering the right test under the right conditions, refusing to diagnose from a single decontextualised value, and treating the person rather than the printout.

When people are referred here

The common doorways: a thyroid test that came back abnormal, a nodule someone felt or a scan found, weight or energy changes with an abnormal result attached, blood sugar that has crossed a line, blood pressure that resists treatment, a calcium level flagged on a routine panel, or a pituitary or adrenal finding on an MRI or CT done for something else. A large share of first consultations end with reassurance and a plan to re-test — which is not a wasted visit; documented normality is one of this specialty’s most underrated products.

Paediatric and reproductive endocrinology

Two neighbouring specialties share the name. A paediatric endocrinologist manages growth, puberty and childhood diabetes within paediatrics; a reproductive endocrinologist works on fertility inside reproductive medicine. Adult gland and metabolic disease — the subject of this guide — is the third branch, and knowing which of the three you need saves a misdirected appointment.

How hormone systems work — and why one number is never a diagnosis

Almost every gland in this guide is run on a thermostat. The pituitary sends a stimulating hormone; the gland answers with its own hormone; the answer feeds back and turns the stimulus down. That loop is why endocrine tests come in pairs — TSH with T4, ACTH with cortisol, LH with testosterone — and why a single value without its partner is unreadable: a low hormone with a high stimulus means the gland is failing, while the same low hormone with a low stimulus means the problem sits upstream in the pituitary. It is also why timing matters — cortisol is naturally highest at dawn and lowest at midnight, testosterone is a morning hormone, and a test drawn at the wrong hour manufactures disease that does not exist.

This logic is the key to the whole guide: whenever it says a result “needs confirming”, it is this logic — repeat the test, pair it with its partner, draw it at the right time, off the medicines that distort it — not bureaucratic caution. Over-reading one number is among the commonest causes of endocrine misdiagnosis.

TSH levels, free T4 and T3 — reading thyroid tests properly

TSH levels are where nearly every thyroid story starts: TSH is the pituitary’s thermostat signal to the thyroid, which makes it the most sensitive single test — and the most misread, because it moves opposite to what intuition expects. An underactive thyroid produces a high TSH (the pituitary shouting at a failing gland); an overactive thyroid produces a low TSH (the pituitary silenced by hormone excess). Free T4 is the thyroid’s actual output, and the TSH–T4 pair together tell the story one number cannot.

High TSH — what it can and cannot mean

A high TSH with a low free T4 is overt hypothyroidism. A high TSH with a normal T4 is the far more common grey zone — subclinical hypothyroidism — which is among the most over-treated results in adult medicine and has its own honest discussion on the internal medicine page: persistence across repeat testing, the degree of elevation, antibodies and genuine symptoms decide it, not the first printout. TSH also rises transiently after illness and varies by assay, age and even season — one reason a mildly high value is confirmed before it is ever treated.

Low TSH — the opposite signal

A low TSH with a high free T4 or T3 is overt hyperthyroidism and gets the work-up in its own section. A low TSH with normal thyroid hormones — subclinical hyperthyroidism — matters more than it looks, particularly in older adults, where it is linked to atrial fibrillation and bone loss and deserves a cause found (often a quietly autonomous nodule) rather than a shrug. And some low TSH is not thyroid disease at all: biotin supplements, recent thyroiditis, pregnancy’s first trimester and serious non-thyroid illness all push TSH around, which is why context reads the test.

Thyroid antibodies and TPO antibodies

Thyroid antibodies answer a different question — not “how is the thyroid working” but “why”. TPO antibodies mark autoimmune thyroid disease: high in most Hashimoto’s, common in Graves’, and present in a meaningful minority of people with completely normal thyroid function, in whom they are a risk marker to watch rather than a disease to treat. TRAb — the receptor-stimulating antibody — is the specific fingerprint of Graves’ disease and earns its place when hyperthyroidism needs a cause named. TPO-antibody levels are not a severity score, and chasing them up and down with repeat testing adds anxiety, not information — TRAb is the exception, legitimately re-measured at defined moments in Graves’ care.

What about T3, reverse T3 and “optimal ranges”?

T3 is the active hormone but a poor screening test — it holds normal until late in hypothyroidism — and reverse T3, heavily promoted online, has no established role in diagnosing or managing thyroid disease in standard practice. The related claim that labs’ reference ranges are wrong and a personal “optimal” TSH should be pursued has a kernel of truth (ranges are population statistics, not personal guarantees) wrapped in a large amount of salesmanship; what actually personalises treatment is symptoms tracked against confirmed, properly timed results — the method of the section on how hormone systems work — not a stricter number bought from a wellness panel.

Hypothyroidism (underactive thyroid)

Hypothyroidism — an underactive thyroid, in the words most British patients meet it under — is the thyroid failing to make enough hormone: metabolism slows, and the classic picture assembles gradually enough that many people blame age or life first. Hypothyroidism symptoms are real but non-specific — fatigue, cold intolerance, weight gain, constipation, dry skin, thinning hair, low mood, brain fog, heavier periods — and that non-specificity cuts both ways: the diagnosis is missed in people who never get tested, and over-claimed in people whose symptoms have other causes and whose thyroid tests are normal. The blood tests settle it, per the testing section; worldwide the leading cause is iodine deficiency, while in iodine-sufficient populations it is Hashimoto’s thyroiditis.

Treatment, honestly framed

The standard treatment is levothyroxine — synthetic T4, identical to the hormone the thyroid makes — taken daily and adjusted against TSH until the level and the person are both steady; the dose is set and changed only by the doctor prescribing it, and questions about how or when to take yours belong in that conversation, because absorption interacts with food, coffee, calcium, iron and other medicines in ways your prescriber will walk through for your exact list. Two honest notes the internet argues about: desiccated thyroid extract (“armour thyroid”) and T4+T3 combinations have persistent advocates and persistently unconvincing trial results — mainstream guidance keeps levothyroxine first for good reason, while acknowledging a small group who feel unwell despite normal numbers and deserve their case examined rather than dismissed. And treatment is not a weight-loss method: correcting a genuinely underactive thyroid removes what the disease added, not what it did not.

Myxoedema — the severe end, named plainly

Untreated severe hypothyroidism can, rarely, progress to myxoedema coma — confusion, hypothermia and slowed body systems. It is a medical emergency treated in hospital, mentioned here not to frighten but because it is the honest reason an “it’s only a thyroid problem” prescription still deserves to be taken, refilled and monitored like the serious medicine it is.

Hashimoto’s thyroiditis (Hashimoto disease)

Hashimoto’s thyroiditis — Hashimoto disease, in the phrasing most searches use — is the immune system slowly attacking the thyroid, and it is the leading cause of hypothyroidism wherever iodine is adequate. It is common, strongly runs in families, affects women several times more often than men, and moves at glacial speed: many people carry the antibodies for years with normal function before the gland finally falls behind. The diagnosis rests on the test pair plus TPO antibodies from the testing section, sometimes with a characteristic ultrasound; treatment, when function fails, is the levothyroxine story under hypothyroidism — the autoimmunity itself is not treated, the hormone shortfall is.

The Hashimoto diet question, answered honestly

The Hashimoto diet is one of the most-searched phrases in all of thyroid disease, and the honest evidence summary is short: no diet has been shown to restore thyroid function or lower antibodies enough to change treatment. Gluten-free eating helps the subgroup with coexisting coeliac disease — worth testing for, since the two cluster — and selenium trials show modest antibody changes without clinical benefit; extreme elimination diets, meanwhile, cost nutrition and money and occasionally delay real treatment. What food genuinely does: very high iodine intake (kelp supplements are the classic culprit) can worsen autoimmune thyroid disease and is worth avoiding, and steady nutrition supports the energy the disease drains. The clinical nutrition unit is the honest partner here — for balance, not for cures.

Living with it: the long arc

Hashimoto’s is a condition you have for decades, and the realistic picture matters: function once lost rarely returns, doses drift over years and around pregnancy and menopause, an annual test is usually enough once stable, and flares of neck discomfort early on can briefly swing hormones before settling. The disease also keeps mild company — slightly higher rates of other autoimmune conditions — which changes vigilance, not daily life. Most people on the right dose live entirely normally, and saying so plainly is part of honest care.

Hyperthyroidism (overactive thyroid)

Hyperthyroidism — an overactive thyroid — is hormone excess: metabolism runs hot, and the body burns through itself. Hyperthyroidism symptoms are the mirror of the underactive list:

• Racing or irregular heartbeat, palpitations
• Weight loss despite a good appetite
• Heat intolerance and sweating
• Tremor, anxiety, irritability, poor sleep
• Frequent bowel movements
• Muscle weakness, especially thighs and shoulders
• Lighter or absent periods

In older adults the picture is quieter and easily missed — sometimes only atrial fibrillation, weight loss or apathy. The tests are the low-TSH story of the testing section; the causes divide into Graves’ disease, autonomously overactive nodules (toxic nodular disease), and the self-limited hormone leak of thyroiditis — and telling them apart matters because their treatments differ completely. That is the first job of the specialist visit, done with antibodies and, where needed, the uptake scan that nuclear medicine runs.

Graves’ disease

Graves’ disease is autoimmune hyperthyroidism: an antibody (TRAb) that impersonates TSH and locks the thyroid’s accelerator on. It is the commonest cause of an overactive thyroid, favours women in young and middle adulthood, runs in families alongside other autoimmunity, and is the one thyroid disease with its own eye condition. Diagnosis is usually straightforward — the hormone pattern plus the antibody — and the real conversation is treatment, because there are three genuinely different doors and the right one depends on you, not on the clinic’s habits.

Graves disease treatment — the three doors

Graves disease treatment is a choice between antithyroid medicines, radioactive iodine and surgery, and an honest clinic lays all three on the table. Medicines (methimazole-class, prescribed and monitored by the treating doctor) calm the gland and give a real chance — very roughly half — of lasting remission after a course of a year or more; their honest costs are relapse risk and rare but serious side effects, including a sudden drop in white blood cells, which is why a sore throat with fever during treatment is checked with an urgent blood count rather than waited out. Radioactive iodine, delivered by nuclear medicine, usually cures the overactivity by retiring the gland (occasionally a second dose is needed) — most people end up on lifelong levothyroxine, which trades a disease for a tablet — and is avoided or delayed with significant eye disease. Surgery, in general surgery’s hands, is the fast definitive door for large goiters, pregnancy-adjacent timing problems, or preference. None of the three is “best”; each is best for someone, and the section exists so you arrive at that conversation already knowing the map.

Thyroid eye disease

Thyroid eye disease — bulging, gritty, watery or aching eyes, double vision, a changed stare — is Graves’ autoimmune twin in the orbit, running its own course that does not always track the hormone levels. Most cases are mild and settle over one to two years; smoking is the single strongest modifiable risk and quitting is the one intervention that helps everything; selenium has evidence in mild disease per the treating doctor; and radioactive iodine can temporarily worsen active eye disease, which is exactly why the three-door treatment choice is made with the eyes in the room. Established or sight-threatening disease is co-managed with ophthalmology, urgently where vision is at risk — a plain fact worth knowing, not a reason for alarm at every dry eye.

Thyroiditis — the inflamed thyroid family

Thyroiditis is inflammation of the thyroid, and its several forms share one useful signature: a stored-hormone leak rather than true overproduction, which is why they often run a three-act course — a hyperthyroid phase as hormone spills, a hypothyroid dip as stores run empty, then recovery over weeks to months. Recognising a leak matters because antithyroid drugs, built for overproduction, do nothing for it; treatment is symptom control and patience, with monitoring to catch the minority whose final act is permanent hypothyroidism.

Subacute thyroiditis — the painful one

Subacute thyroiditis typically follows a viral illness: a genuinely painful, tender neck, sometimes fever, with the leak pattern in the blood tests and a classic ultrasound look. It hurts more than it harms — anti-inflammatory treatment and time settle most cases — and its main danger is being mistaken for something else in either direction, which the combination of story, tenderness and tests prevents.

Postpartum thyroiditis — the one nobody warned you about

Postpartum thyroiditis touches a meaningful minority of women in the year after delivery: a silent, painless version of the same three-act course, its symptoms — anxiety, palpitations, then exhaustion and low mood — so easily filed under “new baby” that most cases are never named. Women with TPO antibodies or type 1 diabetes carry higher risk, a simple test settles the question when the possibility is raised, and while most recover fully, a significant minority keep a permanently underactive thyroid and deserve the follow-up test that catches it. Naming this condition is half of managing it.

Thyroid storm — rare, named plainly

Thyroid storm is severe hyperthyroidism decompensating — high fever, racing heart, agitation or delirium in someone with an overactive thyroid, usually with a trigger such as infection, surgery or abruptly stopped medication. It is rare and it is a medical emergency treated in an intensive-care setting; this guide names it for the same reason it names myxoedema: the honest edges of a disease are part of describing it, and knowing that abruptly abandoning antithyroid treatment is one of its classic triggers is a genuinely useful fact — one more reason changes to those medicines are made with the prescriber, never unilaterally.

Thyroid nodules — the diagnostic pathway, start to finish

A thyroid nodule is a lump in the thyroid, and the two facts that matter most are the two least advertised: thyroid nodules are extraordinarily common — scans find them in a large share of all adults, more with age — and the overwhelming majority are benign and need nothing but, at most, a scheduled look. The entire modern pathway exists to find the small minority that matter without operating on the majority that do not, and this section walks it in order, because knowing the next step is what turns a frightening word into a process.

Step one: thyroid ultrasound and the TIRADS score

A thyroid ultrasound is the first and most important test — not a scan “to see if it’s there” but a structured risk assessment. Modern reporting assigns a TIRADS category: a standardised score built from the nodule’s shape, edges, echo pattern, composition and bright spots, which converts “a 2 cm nodule” into “a 2 cm nodule with a specific, published risk profile”. TIRADS is what decides the next step — low-scoring nodules earn surveillance or discharge whatever their size, higher scores earn a needle — and it is why a thyroid nodule size chart alone cannot answer “is mine dangerous”: size sets follow-up intervals and biopsy thresholds within a risk category, it does not create the risk. Blood tests join the picture for one specific reason: an overactive (“hot”) nodule, confirmed on the scan that nuclear medicine runs, is almost never cancer and is treated as a hormone problem instead.

Step two: thyroid biopsy, demystified

A thyroid biopsy — fine-needle aspiration — is an outpatient test done under ultrasound guidance with a needle thinner than the one that draws blood: a few passes, a plaster, and back to normal activity the same day, with local anaesthetic available and complications genuinely uncommon. Its job is cells, not certainty: the sample goes to pathology, whose page explains the Bethesda categories the answer comes back in — from clearly benign through the indeterminate middle to clearly malignant — and honest counselling before the needle includes the fact that a minority of results land in that indeterminate middle, where molecular testing and the tumour-board conversation with general surgery decide between watching and removing.

Step three: what happens to the majority

Most pathways end here, in one of three calm places: discharge (low-risk look, benign biopsy, or both), scheduled ultrasound surveillance at published intervals, or treatment of a functioning nodule as a hormone problem. Surveillance deserves its honest defence — it is not “doing nothing”, it is the evidence-based response to lesions whose risk of ever mattering is very low, and growth on a schedule is a trigger built into the plan, not a failure of it. The minority with suspicious or malignant results move to surgery with general surgery; thyroid cancer as a whole — worth saying plainly — is among the most treatable cancers there is, and even that word usually begins a measured pathway rather than an emergency.

Thyroid cancer symptoms — and the honest truth about them

Thyroid cancer symptoms are mostly an absence: the typical thyroid cancer is a silent nodule found by a scan or a finger, which is exactly why the diagnostic pathway of this section exists. The features that genuinely raise attention — a nodule that is hard and fixed, growing quickly over weeks, a persistently hoarse voice, trouble swallowing, a new firm lymph node in the neck — are assessed properly when they occur, and still more often have benign explanations. The honest framing is neither “ignore lumps” nor “every lump is a tumour”: it is that a found nodule enters a pathway, and the pathway works.

Goiter (goitre) — the enlarged thyroid

Goiter — goitre in British spelling — simply means an enlarged thyroid, and the word says nothing about cause or function: a goiter can be smooth or nodular, overactive, underactive or hormonally silent. Worldwide the classic cause is iodine deficiency; in iodine-sufficient settings most goiters are multinodular and slowly acquired. What decides management is function and pressure: the tests of the testing section, an ultrasound mapping any nodules into the nodule pathway, and an honest question about whether the gland is actually compressing anything — swallowing, breathing, the look of the neck — or merely visible on a scan.

Toxic multinodular goiter

A toxic multinodular goiter is the nodular gland that has developed autonomous, TSH-ignoring territories — a common cause of hyperthyroidism in older adults, typically milder and more gradual than Graves’ but permanent rather than remitting, which is why its definitive treatments are the radioactive iodine or surgery doors of the three-door discussion rather than long-term tablets alone. Large or compressive goiters, toxic or not, earn the surgical conversation with general surgery; the decision is made on symptoms, anatomy and your other health, not on the gland’s size alone.

After thyroidectomy — the hormone side of thyroid surgery

Thyroidectomy itself — the operation, its risks, its recovery — belongs to general surgery; what belongs here is everything hormonal that follows, because the surgery’s success is judged for years in an endocrine clinic. After total thyroidectomy, levothyroxine is lifelong and the early months are dose-finding months: levels are checked and adjusted on a schedule, and feeling flat while the dose settles is common and temporary. After removal of half the gland, the remaining half manages alone in most people — but not all, which is why a follow-up test some weeks later is part of the plan rather than an optional extra. Two specifics worth knowing: calcium can dip after total thyroidectomy while the parathyroids recover from the disturbance — tingling around the mouth or in the fingertips in the first days is the classic sign, checked promptly with a blood test — and when surgery was for cancer, the TSH target itself becomes a treatment decision, set deliberately by the team rather than aimed at the middle of the range.

The adrenal glands — cortisol, and the art of not over-diagnosing it

The adrenal glands sit on top of the kidneys making cortisol — the stress and energy hormone — along with aldosterone, which manages salt and blood pressure, and adrenaline. Adrenal medicine is where the one-number trap of the feedback-loop section bites hardest: cortisol swings by the hour by design, highest at dawn and lowest at midnight, rises with stress, illness, poor sleep and oestrogen pills, and therefore cannot be interpreted from a single random blood draw — ever. The three honest questions of this territory are: is there genuinely too much cortisol, genuinely too little, or — most often — a normal system being measured badly?

High cortisol: Cushing syndrome symptoms and the cortisol test

High cortisol, sustained for real, produces Cushing syndrome — and its symptoms are a pattern, not a feeling: weight gathering centrally while arms and legs thin, a rounded reddened face, purple stretch marks that are wide and livid rather than pale, skin that bruises at a touch, proximal muscles too weak to rise from a squat, new diabetes and hypertension arriving together. Cushing syndrome symptoms overlap with common life (weight gain, tiredness, low mood), which is why diagnosis never rests on appearance or a single value: the cortisol test for this question is really a family of tests built for the rhythm — late-night salivary cortisol, overnight suppression testing, 24-hour urine — repeated for consistency. One caveat that saves misdiagnosis: the commonest cause of a Cushing-like picture is not a tumour at all but steroid medicines taken for other conditions, a possibility reviewed before any hunt begins — and never adjusted on your own, per the deprescribing rule this platform repeats deliberately.

Cushing disease vs Cushing syndrome

Cushing disease is one specific cause of Cushing syndrome: a small pituitary tumour driving the adrenals via ACTH — the distinction matters because its treatment is pituitary surgery in neurosurgery’s hands, while adrenal causes are treated at the adrenal and medicine-induced cases are treated by fixing the medicines. Locating the driver is careful, sequenced hormone detective work — ACTH levels, imaging aimed only after biochemistry points somewhere — and it is precisely the kind of case a tumour-board hospital handles better than a walk-in scan.

Low cortisol — adrenal insufficiency and Addison’s disease

Low cortisol — adrenal insufficiency, with Addison’s disease as its autoimmune primary form — is the rarer, more dangerous direction: fatigue, weight loss, nausea, low blood pressure and dizziness on standing, salt craving, and in the primary form a distinctive darkening of skin creases and scars. It is confirmed with morning cortisol and stimulation testing, treated with replacement steroids managed by the treating doctor, and it carries the one piece of safety information every affected person is taught: replacement doses must rise during significant illness and must never stop abruptly — an adrenal crisis (vomiting, collapse, confusion in someone on replacement or with known disease) is a medical emergency treated in hospital with an urgent steroid injection. People with the diagnosis carry a steroid card precisely so that fact travels with them.

“Adrenal fatigue” — an honest correction

Adrenal fatigue is one of the most-searched terms in hormone medicine, and this guide owes you the straight answer: it is not a recognised medical diagnosis, and careful studies have repeatedly failed to find the “worn-out adrenal” it proposes. The symptoms attached to it — exhaustion, brain fog, cravings, unrefreshing sleep — are entirely real; the explanation and, more to the point, the products sold on the back of it are not, and some “adrenal support” supplements have contained actual steroid hormones, which can genuinely suppress your own adrenal function and turn a false diagnosis into a real one. What an honest work-up looks like: true adrenal insufficiency excluded properly if the picture warrants it, then the genuinely common causes of that symptom cluster examined — sleep apnoea, depression, iron deficiency, thyroid disease, medication effects, overload — the territory internal medicine owns. Being told “your adrenals are fine” is not a dismissal; paired with “so let’s find what is actually wrong”, it is the beginning of the useful path.

Adrenal nodules and incidentalomas

An adrenal nodule found by accident — an adrenal incidentaloma, discovered on a CT or MRI done for something unrelated — is common enough that every modern hospital has a standing pathway for it, and the two-question logic is simple. Question one: is it secreting hormones? A focused biochemical screen (cortisol suppression testing, metanephrines, and aldosterone testing where blood pressure or potassium suggest it) answers this, because even a benign-looking nodule that quietly over-produces deserves treatment. Question two: does it look benign? Size and imaging characteristics — how the radiologists in the imaging unit read density and washout — sort the overwhelmingly benign majority from the few needing more. Most incidentalomas end with reassurance or a single follow-up scan; a functioning or suspicious minority proceed to the adrenal surgery that general surgery performs. What the pathway prevents is the old error in both directions: operating on harmless lumps, and shrugging at hormone-active ones.

Hyperaldosteronism (primary aldosteronism) — the hidden cause of resistant hypertension

Hyperaldosteronism — primary aldosteronism, Conn’s syndrome in older books — is the adrenal over-producing the salt hormone aldosterone, and it is the most under-diagnosed treatable cause of high blood pressure: studies keep finding it in a meaningful share of people with resistant hypertension, most of whom were never tested. The clues are concrete: blood pressure that stays high on three medicines, low potassium (with or without symptoms), hypertension arriving young, or an adrenal nodule already on a scan. Testing starts with a paired blood test — the aldosterone-to-renin ratio — done under the right conditions, because several common blood-pressure medicines distort it and the work-up sequences them deliberately with the prescriber; confirmation and the question of one gland versus both follow in specialist hands. The reason to bother is the payoff: this is one of the few hypertension diagnoses with a targeted fix — surgery for a single overactive gland, a specific medicine class for both — rather than a lifetime of stacking generic tablets. Blood-pressure care itself stays with cardiology; this unit’s job is making sure this cause is not hiding underneath it.

Pheochromocytoma — rare, dramatic, findable

Pheochromocytoma is a rare adrenaline-producing adrenal tumour, and it earns its short section because its story is so distinctive: episodes of pounding headache, drenching sweat and a racing heart with surging blood pressure, arriving in waves and settling between. Most people investigated for it turn out to have something commoner — anxiety disorders and ordinary hypertension produce overlapping pictures — and the blood and urine metanephrine tests are excellent at settling the question. When it is found, treatment is surgical removal after careful medical preparation, planned jointly with general surgery and anaesthesia; a minority are hereditary, which makes medical genetics part of the conversation after the diagnosis, not an afterthought.

The pituitary — master-gland problems, medicine first

The pituitary is the pea-sized conductor at the base of the brain that runs the thyroid, adrenals, growth and reproduction — which is why its problems appear throughout this guide as “the upstream cause”. Most pituitary tumours are benign adenomas, many are found incidentally on scans done for other reasons, and the guiding principle of modern care is the one in this section’s title: for several of these conditions, medicine — not an operation — is the first and often the only treatment needed.

Pituitary tumor symptoms — the two families

Pituitary tumor symptoms come in two families that can occur together: hormone effects — a specific hormone too high, or the gland’s outputs failing one by one — and pressure effects, classically headache and loss of the outer edges of vision as a larger tumour touches the optic crossing. Small incidental adenomas frequently cause neither, which is why finding one on a scan starts a hormone screen rather than a panic, and why visual symptoms with a known pituitary finding are assessed without delay.

Prolactinoma — the tumour treated with tablets

Prolactinoma, the commonest hormone-producing pituitary tumour, over-makes prolactin — causing missed periods and milky discharge in women, and low libido, erectile problems and low testosterone in men, which is one reason it is found later in men. It is the clearest example of medicine-first: dopamine-agonist tablets, prescribed and monitored by the treating doctor, normalise prolactin and shrink the tumour in the large majority of people, and surgery is reserved for the exceptions. One caution the internet under-teaches: mildly raised prolactin has many non-tumour causes — stress, certain common medicines, an underactive thyroid, even the blood draw itself — so a single high prolactin is repeated and contextualised before anyone says the word tumour.

Acromegaly and the rest of the family

Acromegaly — growth hormone excess in adulthood — announces itself in slow motion: rings and shoes that no longer fit, coarsening features an old photograph makes obvious, sweating, snoring, aching joints; it is diagnosed with IGF-1 testing and treated with surgery, medicines or radiotherapy in combination. Cushing disease has its own discussion in the adrenal section; failing pituitary output (hypopituitarism) is replaced hormone by hormone; and diabetes insipidus — a pituitary water-balance problem of extreme thirst and constant dilute urination, unrelated to blood sugar despite the name — is confirmed with structured testing and treated effectively. Where an operation is the answer, the endoscopic route through the nose belongs to neurosurgery, with this unit managing the hormones before and after — the partnership these tumours are best served by.

Hyperparathyroidism and high calcium

Hyperparathyroidism is the commonest reason a routine blood panel returns a high calcium: one of the four rice-grain parathyroid glands behind the thyroid develops a benign overactive adenoma and keeps calcium high on purpose. Its reputation as “asymptomatic” deserves the honest asterisk — bones thin quietly, kidney stones form, and many people only recognise the fatigue, aching and low mood it caused after treatment lifts them — which is why the classic teaching phrase was “bones, stones, groans and moans”. High calcium found on a screen is first simply confirmed (repeat, corrected for albumin, with vitamin D checked), then paired with the parathyroid hormone level, and that pair usually names the cause in one step, per the feedback-loop logic.

Who needs an operation — and who can watch

The definitive treatment is removing the overactive gland — a focused operation in general surgery’s endocrine hands, guided by the localising scan nuclear medicine performs — and published criteria decide who genuinely benefits: significant calcium elevation, kidney involvement, thinning bones on DEXA, younger age, or symptoms. People outside those criteria can reasonably monitor, with calcium, kidney function and bone density on a schedule; that is a legitimate plan, not neglect. The mirror condition, hypoparathyroidism — low calcium after neck surgery or from autoimmune causes — is managed with calcium and active vitamin D by the treating team, and its tingling-and-cramps warning picture is the same one described after thyroidectomy. Other causes of high calcium exist and matter — some malignancies raise calcium, which is one reason confirmation and the hormone pair come before conclusions.

Diabetes in an endocrine clinic — types, targets and the atypical middle

Diabetes is the metabolic half of this specialty’s name, and an endocrine clinic’s particular contributions are three: getting the type right, setting targets that fit the person, and running the technology and edge cases that generalist care hands over. Type 1 diabetes is autoimmune insulin deficiency and is insulin-treated from day one; type 2 diabetes is insulin resistance plus a beta-cell that cannot keep up, managed with lifestyle change and a now-genuinely-good toolkit of medicines chosen and sequenced by the treating team. Around them sit the states this guide treats as first-class topics rather than footnotes: prediabetes — the warning years in which change genuinely pays — and the honest fact that insulin resistance underlies most type 2 and much of PCOS. The neighbouring units carry their own pieces: screening in check-up, food in clinical nutrition, surgical options for obesity with type 2 diabetes in bariatric surgery, pregnancy diabetes in perinatology, and the eye, kidney and nerve complications with ophthalmology, nephrology and neurology.

LADA diabetes — the adult who “failed” type 2 treatment

LADA diabetes — latent autoimmune diabetes in adults — is type 1’s slow-motion adult form: autoimmune, antibody-positive, but progressing gradually enough that it is routinely mislabelled type 2 for years. The tell is the story: a slim or normal-weight adult whose tablets work briefly and then keep failing, often with other autoimmunity in the background. Antibody testing (GAD antibodies chiefly) and C-peptide — a measure of your own remaining insulin production — settle it, and the label matters practically: LADA needs insulin sooner, and some type 2 medicines are the wrong tools for it. If a diabetes course has felt like constant unexplained failure, asking whether the type was ever actually confirmed is a legitimate, answerable question.

MODY diabetes — the strong family story

MODY diabetes — maturity-onset diabetes of the young — is a family of single-gene diabetes forms, classically appearing before the mid-twenties in lean people with diabetes in several consecutive generations. It hides inside both other labels, and unmasking it changes treatment concretely: some MODY types respond beautifully to specific tablets and need no insulin at all, and one common type needs essentially no treatment — which also rewrites what relatives should be told. Diagnosis is genetic, through medical genetics, and the candidates worth testing are exactly the ones the family story flags.

What is a good A1C?

What is a good A1C? The honest answer is: a target chosen for you, not a universal number. Many guidelines anchor around seven percent for many non-pregnant adults — but tighter targets suit some young, otherwise-healthy people, and deliberately looser ones protect older adults, anyone with frequent low sugars, and people whose other conditions make hypoglycaemia the greater danger. A1C also has honest blind spots — anaemia and some conditions distort it, and it averages away the swings that continuous glucose monitoring reveals — so modern clinics read it alongside time-in-range rather than worshipping it alone. The number to pursue is the one your team writes down with reasons attached; a neighbour’s target is a fact about the neighbour.

The sharp edges, named plainly

Two states deserve their plain-language sentence. Diabetic ketoacidosis — the dangerous acid build-up of severe insulin deficiency, with deep breathing, vomiting, abdominal pain and drowsiness over hours to a day, classically in type 1 or when insulin is interrupted — is a medical emergency treated in hospital. And severe hypoglycaemia — confusion or unconsciousness from very low sugar — is treated immediately wherever it happens, which is why people on insulin or sulfonylurea-class tablets are taught the response and their households are too. Neither fact is meant to alarm; both are why diabetes education is treatment, not paperwork.

Low testosterone, honestly assessed

Low testosterone is one of the most advertised diagnoses in medicine, and the honest version is narrower and more useful than the billboards: testosterone genuinely declines with illness, obesity, sleep apnoea, opioids and some medicines — and modestly with age — and true hypogonadism (low levels plus the symptom pattern) is real and treatable. The assessment that separates marketing from medicine is concrete: symptoms first (low libido and erectile change are the most specific; tiredness alone is a weak signal), then a properly done level — morning, fasting-consistent, repeated on a second day, because testosterone fails the one-number rule of the feedback-loop section as badly as any hormone — then the LH/FSH pair to locate the cause, which occasionally uncovers something upstream such as the prolactinoma described in the pituitary section. Whether replacement is right, in what form, and with what monitoring is a decision made with the treating doctor with fertility explicitly on the table — replacement suppresses sperm production, a fact every man considering it deserves to hear before the first prescription rather than after. The urological side of male health lives with urology, and the two clinics share this territory deliberately.

Women’s hormone questions that land in endocrinology

Much of women’s hormonal health is deliberately owned elsewhere on this platform — PCOS as a condition, contraception, fertility and menopause live with gynaecology and reproductive medicine — but three questions arrive here often enough to deserve their honest paragraph. The metabolic side of PCOS — insulin resistance, weight regulation, diabetes risk, and screening for both — is genuinely endocrine territory and is co-managed with gynaecology rather than competed over. Thyroid disease clusters in women and interacts with every reproductive stage: it is checked in recurrent miscarriage and subfertility work-ups, managed around pregnancy with perinatology where stakes are higher, and — per the postpartum thyroiditis discussion — deserves a lower threshold of suspicion in the exhausted first postpartum year. And hirsutism or new androgen-excess signs get a structured hormonal look when they are more than cosmetic — occasionally they are the presenting edge of an adrenal or ovarian cause worth finding.

Bones and hormones — the endocrine causes of bone loss

Osteoporosis as a disease — DEXA scanning, fracture risk and its treatments — is owned on this platform by rheumatology; endocrinology’s specific job is the checklist behind the diagnosis, because a meaningful minority of bone loss has a hormonal driver that changes everything: hyperparathyroidism, cortisol excess, an over-replaced or overactive thyroid, hypogonadism in either sex, and early menopause. The practical rule this section exists to state: unexplained or unusually early osteoporosis — especially with fractures out of proportion to age — earns a hormonal screen before a lifetime of bone medicines, because treating the cause beats treating around it.

Coming from abroad for endocrine care — the practical shape

Endocrinology travels unusually well as a documents-first specialty: most of its raw material is blood results, scan reports and medication lists, so a meaningful assessment can begin remotely — records reviewed, the missing or badly-timed tests identified in advance — before any flight is booked. The practical fact that shapes an endocrine trip is timing: several of this guide’s key tests have conditions attached — morning draws for cortisol and testosterone, medicine sequencing before aldosterone testing, fasting for metabolic panels — and a visit planned around those conditions gets in one trip what a casual itinerary needs two for. Nodule pathways compress well (ultrasound, TIRADS scoring and biopsy can run in days, with pathology to follow); starting or changing long-term hormone treatment compresses less well, because titration is measured in weeks — which is why plans made here are written explicitly for handover, with targets, intervals and the next decision point stated so the oncoming doctor at home continues a plan rather than restarting one.